Skip to main

Designation of Eculizumab (rmc) (Soliris) as an orphan drug - Alexion Pharmaceuticals Australasia

This item is authorised by the following title:

Latest version
C2017G0013002 February 2017

Downloads

Access downloadable documents for version effective 02 February 2017